Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Virpax Pharmaceuticals Inc | VRPX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 3.17 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.17 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 2.402 - 11.774 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 3.17 | USD |
Virpax Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.71M | 1.17M | - | 0 | -15.19M | -12.97 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Virpax Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRPX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.31 | 4.04 | 3.00 | 3.56 | 11,638 | -0.14 | -4.23% |
| 1 Month | 3.72 | 4.27 | 3.00 | 3.77 | 8,716 | -0.55 | -14.78% |
| 3 Months | 3.20 | 5.48 | 2.64 | 3.78 | 63,876 | -0.03 | -0.94% |
| 6 Months | 7.30 | 8.00 | 2.402 | 3.81 | 169,757 | -4.13 | -56.58% |
| 1 Year | 7.30 | 11.774 | 2.402 | 4.57 | 99,683 | -4.13 | -56.58% |
| 3 Years | 43.90 | 359.799 | 2.402 | 103.76 | 710,983 | -40.73 | -92.78% |
| 5 Years | 80.00 | 359.799 | 2.402 | 102.81 | 682,530 | -76.83 | -96.04% |
Virpax Pharmaceuticals Description
| Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray. |
